Strontium ranelate rebalances bone marrow adipogenesis and osteoblastogenesis in senescent osteopenic mice through NFATc/Maf and Wnt signaling.

Aging cell 20120601

Strontium ranelate--a promising therapeutic principle in osteoporosis.

Journal of trace elements in medicine and biology : organ of the Society for Minerals and Trace Elements (GMS) 20120601

Osteoporosis treatment in postmenopausal women with pre-existing fracture.

Taiwanese journal of obstetrics & gynecology 20120601

Persistence and compliance of medications used in the treatment of osteoporosis--analysis using a large scale, representative, longitudinal German database.

International journal of clinical pharmacology and therapeutics 20120501

Effects of strontium ranelate on cortical bone collagen integrity.

Saudi medical journal 20120501

Oral bisphosphonate use increases the risk for inflammatory jaw disease: a cohort study.

Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons 20120401

Adherence to therapeutic and diagnostic recommendations in patients with femur fracture and at risk of re-fracture or death: results of an analysis of administrative databases.

Reumatismo 20120316

Osteoporosis, osteopenia and fracture risk: widening the therapeutic horizons.

South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde 20120308

[Alopecia areata universalis due to strontium ranelate].

Medicina clinica 20120303

Maintenance of antifracture efficacy over 10 years with strontium ranelate in postmenopausal osteoporosis.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20120301

Individualizing osteoporosis therapy.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20120301

Strontium ranelate prevents bone loss in a rat model of localized muscle paralysis.

Annals of biomedical engineering 20120301

Long-term treatment of osteoporosis in postmenopausal women: a review from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) and the International Osteoporosis Foundation (IOF).

Current medical research and opinion 20120301

Strontium ranelate: too many adverse effects.

Prescrire international 20120301

Effects of strontium on proliferation and differentiation of rat bone marrow mesenchymal stem cells.

Biochemical and biophysical research communications 20120224

Possible benefits of strontium ranelate in complicated long bone fractures.

Rheumatology international 20120201

The use of combination therapy in the treatment of postmenopausal osteoporosis.

Endocrine 20120201

Efficacy and safety of oral strontium ranelate for the treatment of knee osteoarthritis: rationale and design of randomised, double-blind, placebo-controlled trial.

Current medical research and opinion 20120201

EMAS clinical guide: selective estrogen receptor modulators for postmenopausal osteoporosis.

Maturitas 20120201

Extraskeletal benefits and risks of calcium, vitamin D and anti-osteoporosis medications.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20120201

Hemorheological changes with strontium ranelate treatment do not seem to be related to its claimed prothrombotic effects.

Archives of gerontology and geriatrics 20120101

The effect of prior bisphosphonate therapy on the subsequent therapeutic effects of strontium ranelate over 2 years.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20120101

Microarchitecture and nanomechanical properties of trabecular bone after strontium administration in osteoporotic goats.

Biological trace element research 20120101

The intact strontium ranelate complex stimulates osteoblastogenesis and suppresses osteoclastogenesis by antagonizing NF-κB activation.

Molecular and cellular biochemistry 20120101

Effects of strontium ranelate and alendronate on bone microstructure in women with osteoporosis. Results of a 2-year study.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20120101

Persistence with osteoporosis medications among postmenopausal women in the UK General Practice Research Database.

Menopause (New York, N.Y.) 20120101

Weak effect of strontium on early implant fixation in rat tibia.

Bone 20120101

Combination of Micronutrients for Bone (COMB) Study: bone density after micronutrient intervention.

Journal of environmental and public health 20120101

Hip cortical thickness assessment in postmenopausal women with osteoporosis and strontium ranelate effect on hip geometry.

Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry 20120101

Strontium ranelate treatment improves oxidative damage in osteoporotic rat model.

Pharmacological reports : PR 20120101

Sequential osteoporosis treatments.

Joint, bone, spine : revue du rhumatisme 20111201

Prevention of osteoporosis: one step forward, two steps back.

Menopause international 20111201

A comparison of the acute effects of calcium and strontium ranelate on the serum marker of bone resorption.

Clinical chemistry and laboratory medicine 20111114

Current options for the management of postmenopausal osteoporosis.

Expert opinion on pharmacotherapy 20111101

Increased strontium uptake in trabecular bone of ovariectomized calcium-deficient rats treated with strontium ranelate or strontium chloride.

Journal of synchrotron radiation 20111101

[Strontium ranelate promotes osteogenic differentiation of rat bone marrow mesenchymal stem cells by increasing bone morphogenetic protein-7 expression].

Nan fang yi ke da xue xue bao = Journal of Southern Medical University 20111101

Stevens-Johnson syndrome due to strontium ranelate.

Annals of the Academy of Medicine, Singapore 20111101

The mechanism of Cordyceps sinensis and strontium in prevention of osteoporosis in rats.

Biological trace element research 20111001

[Adverse drug reactions of strontium ranelate(Protelos(®) in France].

Presse medicale (Paris, France : 1983) 20111001

[Strontium ranelate(Protelos®): who really benefits of the doubt?].

Presse medicale (Paris, France : 1983) 20111001

The action of Strontium ranelate: myth or reality.

Journal of the Medical Association of Thailand = Chotmaihet thangphaet 20111001

The effect of PTH(1-84) or strontium ranelate on bone formation markers in postmenopausal women with primary osteoporosis: results of a randomized, open-label clinical trial.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20110901

Distribution of strontium and mineralization in iliac bone biopsies from osteoporotic women treated long-term with strontium ranelate.

European journal of endocrinology 20110901

Gastrointestinal tolerability and patterns of switching in patients treated for primary osteoporosis: the Swedish Adherence Register Analysis (SARA).

Calcified tissue international 20110901

Effects of anti-osteoporosis medications on fracture healing.

Current osteoporosis reports 20110901

Strontium ranelate inhibits key factors affecting bone remodeling in human osteoarthritic subchondral bone osteoblasts.

Bone 20110901

Atypical femoral fractures during prolonged use of bisphosphonates: short-term responses to strontium ranelate and teriparatide.

The Journal of clinical endocrinology and metabolism 20110901

Uses and misuses of statistics: the case of strontium ranelate and the number needed to treat.

Journal of endocrinological investigation 20110901

Vertebral fractures.

The New England journal of medicine 20110818

[Pharmacologic treatment of osteoporosis--2011].

Orvosi hetilap 20110814

Anabolic agents and bone quality.

Clinical orthopaedics and related research 20110801

A meta-analysis of the effect of strontium ranelate on the risk of vertebral and non-vertebral fracture in postmenopausal osteoporosis and the interaction with FRAX(®).

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20110801

Adverse reactions and drug-drug interactions in the management of women with postmenopausal osteoporosis.

Calcified tissue international 20110801

An Akt-dependent increase in canonical Wnt signaling and a decrease in sclerostin protein levels are involved in strontium ranelate-induced osteogenic effects in human osteoblasts.

The Journal of biological chemistry 20110708

[Osteoporosis].

Praxis 20110706

How strontium ranelate, via opposite effects on bone resorption and formation, prevents osteoporosis.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20110601

Strontium ranelate: too many adverse effects.

Prescrire international 20110601

Comparative effects of teriparatide and strontium ranelate in the periosteum of iliac crest biopsies in postmenopausal women with osteoporosis.

Bone 20110501

Increased bone strength is associated with improved bone microarchitecture in intact female rats treated with strontium ranelate: a finite element analysis study.

Bone 20110501

Teriparatide [rhPTH (1-34)], but not strontium ranelate, demonstrated bone anabolic efficacy in mature, osteopenic, ovariectomized rats.

Endocrinology 20110501

Strontium ranelate effect in postmenopausal women with different clinical levels of osteoarthritis.

Climacteric : the journal of the International Menopause Society 20110401

The possible introduction of anti-osteoporosis drugs as an integrated treatment in total hip arthroplasty.

Aging clinical and experimental research 20110401

Cost-effectiveness of Denosumab for the treatment of postmenopausal osteoporosis.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20110301

Risk of femoral shaft and subtrochanteric fractures among users of bisphosphonates and raloxifene.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20110301

Strontium ranelate-induced DRESS syndrome with persistent autoimmune hepatitis.

Acta dermato-venereologica 20110301

The treatment of symptomatic osteoporotic spinal compression fractures.

The Journal of the American Academy of Orthopaedic Surgeons 20110301

[Incidence of hip fractures due to osteoporosis in relation to the prescription of drugs for their prevention and treatment in Galicia, Spain].

Atencion primaria 20110201

Strontium ranelate and risk of vertebral fractures in frail osteoporotic women.

Bone 20110201

Strontium is incorporated into the fracture callus but does not influence the mechanical strength of healing rat fractures.

Calcified tissue international 20110201

[Strontium ranelate-induced DRESS syndrome].

Annales de dermatologie et de venereologie 20110201

Strontium ranelate decreases the incidence of new caudal vertebral fractures in a growing mouse model with spontaneous fractures by improving bone microarchitecture.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20110101

Effect of strontium ranelate on fracture healing in the osteoporotic rats.

Journal of orthopaedic research : official publication of the Orthopaedic Research Society 20110101

Strontium ranelate in post-menopausal osteoporosis.

Endokrynologia Polska 20110101

Activation of FGF receptors is a new mechanism by which strontium ranelate induces osteoblastic cell growth.

Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology 20110101

Trabecular reorganization in consecutive iliac crest biopsies when switching from bisphosphonate to strontium ranelate treatment.

PloS one 20110101

[Strontium ranelate in post-menopausal osteoporosis].

Endokrynologia Polska 20110101

How to manage postmenopausal osteoporosis?

Acta clinica Belgica 20110101

Positive impact of compliance to strontium ranelate on the risk of nonvertebral osteoporotic fractures.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20101201

Effects of strontium ranelate administration on bisphosphonate-altered hydroxyapatite: Matrix incorporation of strontium is accompanied by changes in mineralization and microstructure.

Acta biomaterialia 20101201

Impact of treatments for postmenopausal osteoporosis (bisphosphonates, parathyroid hormone, strontium ranelate, and denosumab) on bone quality: a systematic review.

Calcified tissue international 20101201

Strontium ranelate: a look back at its use for osteoporosis.

Expert opinion on pharmacotherapy 20101201

Systemic treatment with strontium ranelate promotes tibial fracture healing in ovariectomized rats.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20101101

Sustained vertebral antifracture efficacy of oral anti-osteoporotic therapies in postmenopausal osteoporosis.

Current medical research and opinion 20101101

How to prevent glucocorticoid-induced osteoporosis.

Cleveland Clinic journal of medicine 20101101

Evidence-based guidelines for the pharmacological treatment of postmenopausal osteoporosis: a consensus document by the Belgian Bone Club.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20101001

Strontium ranelate decreases receptor activator of nuclear factor-ΚB ligand-induced osteoclastic differentiation in vitro: involvement of the calcium-sensing receptor.

Molecular pharmacology 20101001

Strontium ranelate in osteoporosis and beyond: identifying molecular targets in bone cell biology.

Molecular interventions 20101001

Use of bisphosphonates and raloxifene and risk of deep venous thromboembolism and pulmonary embolism.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20100901

Spotlight on strontium ranelate: in postmenopausal osteoporosis.

Drugs & aging 20100901

Essential role of nuclear factor of activated T cells (NFAT)-mediated Wnt signaling in osteoblast differentiation induced by strontium ranelate.

The Journal of biological chemistry 20100813

Strontium ranelate and alendronate have differing effects on distal tibia bone microstructure in women with osteoporosis.

Rheumatology international 20100801

The Calcium-sensing Receptor (CaR) is involved in strontium ranelate-induced osteoblast differentiation and mineralization.

Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme 20100801

The relationship of inflammation to systemic diseases and chronic periodontitis.

International journal of dental hygiene 20100801

Cost-effectiveness of strontium ranelate for the prevention and treatment of osteoporosis.

Expert review of pharmacoeconomics & outcomes research 20100801

Osteoporosis and venous thromboembolism: a retrospective cohort study in the UK General Practice Research Database.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20100701

Bladder rupture following osteoporotic pubic ramus and sacral insufficiency fractures.

Age and ageing 20100701

Incidence of venous thromboembolism in users of strontium ranelate: an analysis of data from a prescription-event monitoring study in England.

Drug safety 20100701

Relationship between 3-month changes in biochemical markers of bone remodelling and changes in bone mineral density and fracture incidence in patients treated with strontium ranelate for 3 years.